Visualizing drug treatment pathways in type 2 diabetes

被引：0
|
作者：
Patrick, Amanda R. [1 ]
Nemeth, Sheila [1 ]
Adimadhyam, Sruthi [1 ]
机构：
[1] Aetion Inc, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1063
引用
收藏
页码：514 / 514
页数：1
相关论文
共 50 条
  • [1] Visualizing heterogeneity in type 2 diabetes phenotype, outcome and drug response
    Nature Medicine, 2022, 28 : 909 - 910
  • [2] Visualizing heterogeneity in type 2 diabetes phenotype, outcome and drug response
    Pearson, Ewan
    Thakarakkattil, Anand
    Nair, Narayanan
    NATURE MEDICINE, 2022, 28 (05) : 909 - 910
  • [3] Drug treatment for type 2 diabetes
    Pillon, Francois
    Tan, Kimny
    Jouty, Priscilla
    Frullani, Yannick
    ACTUALITES PHARMACEUTIQUES, 2014, 53 (541): : 23 - 28
  • [4] Drug treatment of type 2 diabetes
    Tielmans, Amelie
    Laloi-Michelin, Marie
    Coupaye, Muriel
    Virally, Marie
    Meas, Taly
    Guillausseau, Pierre-Jean
    PRESSE MEDICALE, 2007, 36 (02): : 269 - 278
  • [5] Drug treatment in type 2 diabetes (part 2)
    Tielmans, Amelie
    Virally, Marie
    Coupaye, Muriel
    Laloi-Michelin, Marie
    Meas, Taly
    Guillausseau, Pierre-Jean
    PRESSE MEDICALE, 2007, 36 (03): : 467 - 474
  • [6] Are thiazolidinediones a preferred drug treatment for type 2 diabetes?
    Hurren, Kathryn M.
    Dunham, Marissa Waldman
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (02) : 131 - 133
  • [7] Optimizing drug treatment for patients with type 2 diabetes
    Letonturier, Philippe
    PRESSE MEDICALE, 2007, 36 (05): : 813 - 815
  • [8] Saxagliptin: A New Drug for the Treatment of Type 2 Diabetes
    Thareja, Suresh
    Aggarwal, Saurabh
    Malla, Priyanka
    Haksar, Diksha
    Bhardwaj, Tilak Raj
    Kumar, Manoj
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 759 - 765
  • [9] Drug treatment of diabetes type 2, news and novelties
    Emile, Carole
    ACTUALITES PHARMACEUTIQUES, 2008, 47 (470): : 29 - 30
  • [10] Guideliness for drug treatment of type 2 diabetes mellitus
    Halimi, S
    Rostoker, G
    Altman, JJ
    Attali, C
    Beaune, J
    Belorgey-Bismut, C
    Bouldouyre-Magnier, AM
    Cordonnier, D
    Denis, C
    Duranteau, L
    Grimaldi, A
    Guillausseau, PJ
    Koenig, F
    Lagrue, G
    Monnier, L
    Orgiazzi, F
    Raucoules-Aime, M
    Saltiel, H
    Simon, D
    Varroud-Vial, M
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (02) : 168 - 173
12345